The Wall Street Journal100d agobullish
AbbVie Lowers Outlook to Account for Acquisition as Profit JumpsNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3126last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool131d agobullish
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?